Project Grant R25CA298916
- The National Cancer Institute (NCI) awarded a $159,450 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to Wayne State University to support the "NextGen Oncology Scholars: Nurturing Tomorrow's Pioneers" program. This 5-year grant, beginning August 15, 2025 and ending July 31, 2030, aims to cultivate the next generation of cancer researchers by providing undergraduate students with hands-on research experiences, didactic training, clinical exposure, and structured...
- This federal Project Grant award from the National Cancer Institute (NCI) under CFDA 93.396 (Cancer Biology Research) provides $182,755 to Cold Spring Harbor Laboratory (CSHL) to conduct research on genetic technology development for understanding lineage plasticity mechanisms in cancer. The award began on August 21, 2025 and is scheduled for completion on July 31, 2030. The key products and services to be delivered through this grant include: 1) developing a CRISPR screening methodology for...
- The University of Cincinnati's Sponsored Research Services Division was awarded a $383,491 Project Grant from the National Cancer Institute under the Cancer Research Manpower (CFDA 93.398) federal grant program. The grant, awarded on July 1, 2025 with a completion date of June 30, 2030, will fund a Training Program in Basic and Translational Oncology. The program aims to increase the number of researchers with a strong background in cancer biology who can effectively translate scientific...
- The National Cancer Institute awarded a $145,937 Project Grant (CFDA 93.398 Cancer Research Manpower) to the University of Utah's Huntsman Cancer Institute to support the Oncological Data Science (ODSI) Training Program. This two-year predoctoral program will provide comprehensive, multidisciplinary training in cancer biology, bioinformatics, epidemiology, and data science to prepare young scientists to become "data ambassadors and data innovators" advancing cancer research through...
- This $292,028 Project Grant awarded by the National Cancer Institute (CFDA 93.398 - Cancer Research Manpower) supports research to investigate the mechanisms by which oncogene amplification leads to genome instability and the development of therapy-resistant cancer clones. The research will be conducted by the Sloan-Kettering Institute for Cancer Research in New York and is scheduled to run from August 1, 2025 to July 31, 2030. Using single-cell genomic sequencing techniques, the project aims...
- The National Cancer Institute (CFDA 93.396 - Cancer Biology Research) awarded a $1,625,853 Project Grant to New York University (NYU) on December 13, 2024. The grant will support NYU's research to map and characterize the role of 3D "hubs" - regulatory DNA elements that interact with multiple loci - in the context of T-cell leukemia (T-ALL), early T-cell progenitor leukemia (ETP-ALL), and T-cell lymphoma. The project aims to better define how these 3D chromatin structures are rewired...
- The U.S. National Cancer Institute (NCI) awarded a $122,032 Project Grant under the Cancer Research Manpower (CFDA 93.398) program to Weill Medical College of Cornell University. The grant, with a period of performance from February 1, 2025 to January 31, 2027, will fund research to study the role of aberrant mRNA splicing in cancer cell heterogeneity and its potential as a target for immunotherapeutic strategies. The research aims to utilize advanced computational and single-cell approaches...
- This Project Grant award, totaling $102,984, was provided by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) federal grant program. The award supports research by The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, to perform spatio-temporal analyses of the entire brain-metastatic arc, from single-cell interaction with the blood-brain-barrier to fully developed brain metastases. The research will...
- The National Cancer Institute awarded a $307,680 Project Grant to the University of Wisconsin-Madison (UW) under the Cancer Research Manpower (CFDA 93.398) program. The grant, titled "ASSURE ADVANCED RADIOLOGICAL SCIENCES PROGRAM," aims to establish an immersive summer research experience in radiological sciences for 17 undergraduate students. The program will provide cancer-focused scientific training, including didactic lectures, mentored research experiences, and interactive...
- The National Cancer Institute awarded a $324,000 Project Grant to The Medical College of Wisconsin, Inc. under the Cancer Research Manpower (CFDA 93.398) program. The goal of this 5-year grant, awarded on August 7, 2025, is to collaborate with community partners to identify and educate a group of undergraduate students (SPARCC Scholars) from surrounding Milwaukee-area institutions who wish to develop careers in biomedical, behavioral, and clinical cancer research. The program will provide SPARCC...
The National Cancer Institute (NCI) has awarded a Project Grant under the Cancer Research Manpower Program (CFDA 93.398) to Cold Spring Harbor Laboratory (CSHL) for the "CSHL Course on Methods in Cancer Neuroscience" from 2025-2029. The $213,589 award will support a 16-day intensive, hands-on training course that prepares students to conduct advanced molecular and cellular techniques in cancer neuroscience research. The course will cover experimental modules such as cell injections, viral injections, in vivo electrophysiology, microscopy techniques, and bioinformatics analysis. The program aims to develop the next generation of cancer researchers by providing specialized training to graduate students, postdoctoral fellows, and early-career investigators. The course will feature lectures from leading experts in the field and accept trainees through a competitive selection process.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $213.6k | 9/4/25 |